Related Experiment Video
Updated: Jun 12, 2026

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
The BRACELET Study: surveys of mortality in UK neonatal and paediatric intensive care trials
Claire Snowdon1, Sheila E Harvey, Peter Brocklehurst
1Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, UK.
Insights
Deaths in pediatric and neonatal intensive care trials are common, yet few trials have bereavement support policies. This study highlights the need for developing and assessing bereavement care strategies in clinical trials.
Area of Science:
- Pediatric Intensive Care
- Neonatal Intensive Care
- Clinical Trials
- Bereavement Studies
Background:
- Research on death and bereavement in pediatric and neonatal intensive care randomized controlled trials (RCTs) is limited.
- The Bereavement and RAndomised ControlLEd Trials (BRACELET) Study aimed to assess trial activity, mortality, and bereavement support policies in UK NICUs and PICUs between 2002-2006.
- Understanding these factors is crucial for developing future policies and practices for bereavement support following a child's trial enrollment.
Purpose of the Study:
- To determine the extent of trial activity in UK neonatal and paediatric intensive care units from 2002 to 2006.
- To quantify the number of deaths occurring before hospital discharge among participants in these trials.
- To examine variations in mortality rates across different intensive care units and trials, and to assess the availability of bereavement support policies within trials.
Main Methods:
- A survey of neonatal units (level 2 or 3 care) and paediatric units (level II care or above) in the UK.
- A survey of randomized controlled trials involving intensive care patients or parents, with interventions designed to affect patient outcomes.
- Data collection on trial participation, patient enrollment, mortality, and existing bereavement support policies.
Main Results:
- Information was gathered from 191 neonatal and 28 paediatric units, with 90 units participating in at least one trial.
- Fifty trials were identified, enrolling 3,137 infants in neonatal trials and 210 children in paediatric trials.
- A total of 534 participants (16%) died post-enrollment (522 in neonatal, 12 in paediatric trials); only three trials reported a formal bereavement policy.
Conclusions:
- A significant number of deaths occurred among participants enrolled in neonatal and paediatric intensive care trials.
- Bereavement support policies were largely absent within the studied trials.
- Units and trials with higher mortality rates may be best positioned to lead the development and evaluation of bereavement support strategies.
Background:
The subject of death and bereavement in the context of randomised controlled trials in neonatal or paediatric intensive care is under-researched. The objectives of this phase of the Bereavement and RAndomised ControlLEd Trials (BRACELET) Study were to determine trial activity in UK neonatal and paediatric intensive care (2002-06); numbers of deaths before hospital discharge; and variation in mortality across intensive care units and trials and to determine whether bereavement support policies were available within trials. These are essential prerequisites to considering the implications of future policies and practice subsequent to bereavement following a child's enrollment in a trial.
Methods:
The units survey involved neonatal units providing level 2 or 3 care, and paediatric units providing level II care or above; the trials survey involved trials where allocation was randomized and interventions were delivered to intensive care patients, or to parents but designed to affect patient outcomes.
Results:
Information was available from 191/220 (87%) neonatal units (149 level 2 or 3 care); and 28/32 (88%) paediatric units. 90/177 (51%) eligible responding units participated in one or more trial (76 neonatal, 14 paediatric) and 54 neonatal units and 6 paediatric units witnessed at least one death. 50 trials were identified (36 neonatal, 14 paediatric). 3,137 babies were enrolled in neonatal trials, 210 children in paediatric trials. Deaths ranged 0-278 (median [IQR interquartile range] 2 [1, 14.5]) per neonatal trial, 0-4 (median [IQR] 1 [0, 2.5]) per paediatric trial. 534 (16%) participants died post-enrollment: 522 (17%) in neonatal trials, 12 (6%) in paediatric trials. Trial participants ranged 1-236 (median [IQR] 21.5 [8, 39.8]) per neonatal unit, 1-53 (median [IQR] 11.5 [2.3, 33.8]) per paediatric unit. Deaths ranged 0-37 (median [IQR] 3.5 [0.3, 8.8]) per neonatal unit, 0-7 (median [IQR] 0.5 [0, 1.8]) per paediatric unit. Three trials had a formal policy for responding to bereavement.
Conclusions:
A substantial number of deaths after trial enrollment were identified, distributed over many trials and units. Few trial teams had responses to bereavement in place. Those with the largest numbers of deaths might be best placed to collaborate in developing and assessing responses to bereavement.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials: Overview
Longitudinal Studies
